Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points
- 15 February 2021
- journal article
- review article
- Published by Taylor & Francis Ltd in RNA Biology
- Vol. 18 (5), 688-695
- https://doi.org/10.1080/15476286.2021.1885188
Abstract
The COVID-19 emergency pandemic resulting from infection with SARS-CoV-2 represents a major threat to public health worldwide. There is an urgent clinical demand for easily accessible tools to address weaknesses and gaps in the management of COVID-19 patients. In this context, transcriptomic profiling of liquid biopsies, especially microRNAs (miRNAs), has recently emerged as a robust source of potential clinical indicators for medical decision-making. Nevertheless, the analysis of the circulating miRNA signature and its translation to clinical practice requires strict control of a wide array of methodological details. In this review, we indicate the main methodological aspects that should be addressed when evaluating the circulating miRNA profiles in COVID-19 patients, from preanalytical and analytical variables to the experimental design, impact of confounding, analysis of the data and interpretation of the findings, among others. Additionally, we provide practice points to ensure the rigour and reproducibility of miRNA-based biomarker investigations of this condition. Abbreviations: ACE: angiotensin-converting enzyme; ARDS: acute respiratory distress syndrome; COVID-19: coronavirus disease 2019; ERDN: early Detection Research Network; LMWH: low molecular weight heparin; miRNA: microRNA; ncRNA: noncoding RNA; SARS-CoV-2: severe acute respiratory syndrome coronavirus-2; SOP: standard operating procedure.Funding Information
- Instituto de Salud Carlos III (CIBERESUCICOVID, COV20/00110)
This publication has 100 references indexed in Scilit:
- Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker LevelsPLOS ONE, 2013
- Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitationsProceedings of the National Academy of Sciences of the United States of America, 2013
- Use of the Corus® CAD Gene Expression Test for Assessment of Obstructive Coronary Artery Disease Likelihood in Symptomatic Non-Diabetic PatientsPLoS Currents, 2013
- MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophagesJCI Insight, 2012
- Roles for MicroRNAs in Conferring Robustness to Biological ProcessesCell, 2012
- SALL4, a Stem Cell Factor, Affects the Side Population by Regulation of the ATP-Binding Cassette Drug Transport GenesPLOS ONE, 2011
- MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteinsNature, 2011
- Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working GroupJournal of Proteome Research, 2008
- Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery StenosisCirculation: Cardiovascular Genetics, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences of the United States of America, 2008